Skip to main content

ORIGINAL RESEARCH article

Front. Surg., 04 May 2021
Sec. Thoracic Surgery

Thermal Volume Reduction Surgery for Surgical Treatment of Pulmonary Bullae: A Single-Center Treatment Experience of 276 Cases Accompany With Primary Lung Cancer

  • 1Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China
  • 2Department of Thoracic Surgery, Jilin Cancer Hospital, Changchun, China
  • 3Changchun Tumor Hospital, Changchun, China

Objective: Lung volume reduction surgery (LVRS) has been regarded as an effective surgical procedure for severe emphysema (including pulmonary bullae). However, there still remain controversial that its applications limited that only patients with a specific clinical situation may benefit from LVRS, and so did other non-surgical treatments. The current study aims to introduce some initial experience of new technique for treating pulmonary bullae, including using thermal surgical instruments to reduce enlargement of lung tissue in a specific group that diagnosed with lung cancer accompany with pulmonary bullae.

Methods: This retrospective study included 276 patients undergoing emphysema reducing surgery between 2010 and 2020. All procedure were performed by thermal volume reduction surgery of using thermal surgical instruments to reduce pulmonary bullae.

Results: The average time required for operating single pulmonary bullae was <10 min. Median operative time was 106 min (range 85 to 191 min). No intraoperative air leak, massive blood loss, or other severe complications occurred. The estimated blood loss for TVRS was about 40 ml (range 15 to 120 ml). Postoperative complications included atelectasis (n = 8), pulmonary infection (n = 17), bleeding (n = 5), delayed air leak (n = 7) among the cohort. The postoperative lung function at 1-year post surgery in TVRS group recovered faster with a better recovery that achieving an FEV1 of 1.95 ± 0.46 L, TLC of 6.36 ± 0.79 L, RV of 3.56 ± 0.81 L, PO2 of 60 ± 8 mmHg, PCO2 of 37 ± 6 mmHg, and 6 MWD (6-min walk distant) of 305 ± 22 m. The 1-year QOL score was elevated comparing with preoperative period.

Conclusion: This single-center study reported a new thermal-based surgical approach to treat pulmonary bullae by reducing abnormally enlarged lung tissue in specific patients diagnosed with lung cancer accompany with pulmonary bullae.

GRAPHICAL ABSTRACT
www.frontiersin.org

Graphical Abstract. Use electrocautery to undergo the burning procedure to the surface of pulmonary bullae.

Highlights

- This report introduced a lung volume reduction procedure by electrocautery and other thermal ablation procedure.

- Thermal Volume Reduction Surgery (TVRS) had a satisfactory outcome for lung volume reduction in lung cancer patients.

- Thermal Volume Reduction Surgery (TVRS) had a optimizing surgical outcome for treating advanced emphysema.

Introduction

Emphysema is a pathological clinical manifestation of long-term damage to lung function and irreversible dilatation of the terminal bronchioles and alveoli (1). Enlargement of the airspace structure is the main pathological change associated with emphysema, and severe cases may develop into pulmonary bullae, which eventually lead to acute rupture of the lungs (2). Surgery is an effective therapeutic method for severe emphysema, aiming to remove dysfunctional lung tissues, reduce the ventilation–perfusion mismatch, and improve diaphragm function (3).

Lung volume reduction surgery (LVRS) is a surgical procedure commonly used for removing dysfunctional lung tissues (4). LVRS is fundamentally the same as subpulmonary lobectomy. However, LVRS has a high risk of adverse complications, including prolonged air leaks, pneumonia and acute inflammation, which may increase short-term mortality (5). In recent years, implantation of endobronchial Valves and Coils has been approved as a novel treatment for emphysema (6, 7). In 1996, McKenna et al. (8) conducted a randomized trial in which diffuse emphysema patients were treated by laser bullectomy. The results showed a negative outcome from the use of a Nd:YAG contact laser. Thermal vapor ablation has also recently been applied for emphysema (911). Gompelmann et al. (12) reviewed the clinical application of bronchoscopic thermal vapor ablation, suggesting the potential value of thermal procedures in the treatment of emphysema or pulmonary bullae.

Here, we report an improvement in the use of an electric cautery procedure, namely, thermal volume reduction surgery (TVRS), as an alternative to lung tissue dissection for the treatment of emphysema. In principle, this procedure may both ensure the effectiveness of surgical treatment and reduce early-stage morbidity and mortality by reducing lung tissue resection. Notably, we assessed the therapeutic efficacy of TVRS in primary lung cancer patients with pulmonary bullae located in different lobes on the same side to reduce the unnecessary dissection of benign lung tissue.

Patients and Methods

Patients

This study was approved by the Institutional Review Board of Jilin Cancer Hospital (No. 201412-028). Written informed consent was obtained preoperatively from lung cancer patients recruited in our hospital from May 2010 to May 2020. The average age at surgery was 63 years (51–76 years). All patients were diagnosed with primary lung cancer with advanced emphysema or pulmonary bullae on the same side. The inclusion criteria were as follows: (1) Lung cancer and enlargement of lung tissues were preoperatively confirmed by low-dose computed tomography (LDCT), and the pulmonary bullae were near the visceral pleura (Figure 1), and the diameter of pulmonary bullae was not <1.5 cm according to the results of the imaging examination. (2) The pulmonary bullae were located on the same side as the primary lung tumor but not in the lobe invaded by the tumor. (3) Preoperative lung function was strong enough that the patient could tolerate radical resection of the lung tumor. The basic characteristics and perioperative outcomes of included patients were collected to analyze. The postoperative outcomes and quality of life (QOL) was focused on the recovery of pulmonary function in 30 days and 1 years. The QOL were evaluated by St-George Respiratory Questionnaire (SGRQ) (13) improved version. The scoring criteria were summarized by 4 parts (Activities of daily living, Social activities, Depression and Anxiety). In this scoring system, the score is inversely proportional to the quality of life. All the included data in our study was from these 276 patients.

FIGURE 1
www.frontiersin.org

Figure 1. CT screening of included patient, this case had pulmonary bullae located at left upper lobe.

Operation Procedure

The surgical incision was made based on the surgical choice of lung tumor resection, which was not altered by TVRS. Both Video-assisted surgery (VATS) and open surgery are appropriate for the TVRS procedure. The types of surgery used for tumor resection included wedge resection, segmentectomy, and lobectomy.

Procedure Selection and Preparation for Thoracic Surgery

LDCT was preoperatively performed (the threshold was set to −950 EU), and clinical information including the number, location, and pleural adhesion of the bullae and the degree of destruction [evaluated by the emphysema index (EI), which indicates the percentage of low-attenuation area in the total pulmonary volume], was collected. Patients with emphysema may have an abnormal increase in lung volume, and the pressure of local pulmonary bullae increases unevenly, leading to difficulty in the local operation. An example of the surgical view of pulmonary bullae for open surgery is shown in Figure 2A, and the whole procedure is shown in Supplementary Video 1. The hyperinflation of pulmonary bullae should be confirmed by both the imaging examination results and the surgical view. Because this procedure does not require special preparation of surgical instruments, surgeons may evaluate intraoperatively whether this procedure can be performed.

FIGURE 2
www.frontiersin.org

Figure 2. Surgical procedure of TVRS. (A) Pulmonary bullae of lung under operative field. (B) Use electrocautery to undergo the burning procedure to the surface of pulmonary bullae. (C) After the procedure, the abnormally enlarged lung volume will decrease to normal shape (yellow circle).

In the open surgical procedure, the target lung was normally ventilated to expose the emphysema more clearly and to ensure the safety of patients with poor lung function. Airway pressure was continuously monitored during the surgical procedure. Double-lumen endotracheal tubes were used during anesthesia. In the VATS procedure, low-flow ventilation could be performed on the target lung to ensure sufficient operation space.

Surgical Technique for Emphysema

Electric cautery was applied to burn the surface of the emphysema site (Figure 2B). The extension of the cautery area was determined by the preoperative CT scanning result and intraoperative observation of the volume of pulmonary bullae. The whole surface of the bulla was burned, and the cauterized area extended no more than 0.5 cm beyond the boundary of the bulla. The whole cautery procedure was deemed complete once the bullae shrank to the point that they no longer compressed the surrounding lung tissue. Under this procedure, the wall of the emphysema lesion shrank, the volume of the emphysema lesion decreased, and the abnormally enlarged lung eventually shrank to a normal volume (Figure 2C). The following parameters were set: electric cautery = 30 W (output power); distance between cautery burning points = 1–2 cm on the same pulmonary bulla. After volume reduction, the compression of the healthy lung tissue was relieved, and the remaining lung tissue recovered its normal function. The local temperature was over 100°C, and the burning operation was performed carefully to prevent delayed air leakage caused by destruction of the lung tissues through cautery. Since the thickness of the lung tissue on the surface of pulmonary bullae was relatively low and the bulge was obvious, direct use of an electric knife may lead to rupture of lung tissues, resulting in air leakage. If operating conditions permitted, 2 or 3 layers of gauze soaked in normal saline (NS) were applied over the operating surface to cool the tip of the cautery iron, thus avoiding damage to the lung tissues. Then, the burning procedure continued in this manner, aiming to ensure that the lung tissues covered by gauze were evenly heated and that the local temperature was not excessively high. The airway pressure should be stable during the burning procedure. If an air leak occurred, the airway pressure decreased, at which time the lung tissues needed to be repaired immediately to prevent prolonged air leakage.

Postoperative Protection of Lung Tissues

The thoracic cavity and lung surface were flushed with normal saline (NS). The density and toughness of burnt lung tissues were enhanced, and no special material was needed to protect the surgical surface. Meanwhile, due to the increased toughness of the lung tissue, the rate of local rupture of the lung tissue decreased when the airway pressure was increased by coughing.

Statistical Analysis

All the variables were evaluated by t-test. Measurement data that follow a normal distribution are expressed as x¯ ± s. P < 0.05 was considered statistically significant. SPSS Statics software ver. 25.0 (IBM Corporation, NY, USA) was applied to perform all statistical analyses.

Results

From May 2010 to May 2020, a total of 276 eligible patients were chosen from 675 lung cancer patients who underwent surgery in Jilin Cancer Hospital. Their baseline information is shown in Table 1. All recruited patients were diagnosed with primary lung cancer with advanced emphysema, which was clinically manifested as simple or multiple pulmonary bullae located in different lobes from the tumor site. The average time required to operate on single pulmonary bullae was <10 min, and the median operative time was 106 min (85–191 min). No intraoperative air leakage, massive blood loss or other severe complications occurred. The estimated blood loss during TVRS was ~40 ml (15–120 ml). Postoperative complications included atelectasis (n = 8), pulmonary infection (n = 17), bleeding (n = 5), and delayed air leakage (n = 7) (Table 2). At 1 year postoperatively, the TVRS group had recovered its lung function more effectively than the other group, achieving an FEV1 of 1.95 ± 0.46 L, TLC of 6.36 ± 0.79 L, RV of 3.56 ± 0.81 L, PO2 of 60 ± 8 mmHg, PCO2 of 37 ± 6 mmHg, and 6 MWD (6-min walk distant) of 305 ± 22 m (Table 3). The 1-year QOL score was elevated comparing with preoperative period (Table 4).

TABLE 1
www.frontiersin.org

Table 1. Pre-operative clinical characteristics of patients included in series.

TABLE 2
www.frontiersin.org

Table 2. Intraoperative and postoperative outcomes after TVRS surgery in included series.

TABLE 3
www.frontiersin.org

Table 3. Preoperative and postoperative lung function in included series.

TABLE 4
www.frontiersin.org

Table 4. Preoperative and postoperative Quality of life (QOL) score [Based on St-George Respiratory Questionnaire (SGRQ) improved version].

Pathological Results

Cauterized pulmonary tissue specimens were collected during the surgical procedure to observe the pathological changes that occurred during TVRS. Microscopic observation showed that the visceral pleura of the burned area markedly contracted and thickened, and the total volume of the alveoli contracted. TVRS significantly alleviated pathological changes in pulmonary bullae (Figure 3).

FIGURE 3
www.frontiersin.org

Figure 3. Pleural histological structure after thermal procedure. The visceral pleural of the burned area contracted and thickened obviously, and the whole volume of the alveoli contracted.

Discussion

In 1957, Brantigan and Muller (14) first reported a surgical approach known as lung volume reduction surgery, in which the emphysematous part of the lung is resected. The aim is to resect the overexpanding, dysfunctional lung tissues and restore ventilation and perfusion of normal lung tissues, although it has disadvantages such as a high risk of complications and early mortality. At present, the clinical benefits of lung volume reduction surgery remain controversial. The National Emphysema Treatment Trial (NETT) is the largest and most comprehensive multicenter prospective randomized controlled trial (RCT) assessing the LVRS procedure in severe emphysema cases. It has been reported that LVRS is effective in severe emphysema patients and shows acceptable safety in high-risk populations (15). Ginsburg et al. (16) reported a 10-year experience indicating that LVRS is safe and effective for a specific group of patients with emphysema. A recent study from Lim et al. (17) reported that LVRS was more effective than conventional medical treatment in restoring lung function and relieving dyspnea. At present, the nature of a suitable candidate for LVRS is still controversial.

New technologies have gradually developed and expanded the application range of surgical treatment for emphysema. Another novel approach consisting of implantation of endobronchial valves or coils has been recently approved to treat emphysema with intact lobar fissures or absent collateral ventilation (6, 7), although the number of clinical cases is limited. In 2016, Sciurba et al. (18) reported an RCT (RENEW) showing the effectiveness and safety of endobronchial coil treatment for emphysema patients. Slebos et al. (19) identified that CT screening and significant hyperinflation (residual volume≥200% of predicted) are essential for identifying the population that is suitable for endobronchial coil therapy. Other trials (2022) have also indicated the efficiency of implantation of endobronchial valves. As a result, multiple therapeutic approaches may potentially be effective for advanced emphysema and pulmonary bullae, though the REVOLENS trial (23) indicated that endobrochial coil required a higher short-term cost which may influence the cost-effectiveness. As for thermal therapy, bronchoscopic thermal vapor ablation has been noted for its practical advantages endoscopic lung volume reduction (12), although this procedure has been applied at only a limited group of centers, requiring a special surgical instrument, and it cannot be performed in patients with multiple or confluent pulmonary bullae.

The TVRS operation can be regarded as a surgical procedure intermediate between surgery and interventional therapy, wherein the thoracic cavity is exposed without dissecting any lung tissues. Instead, this procedure is performed to reduce the volume of emphysema lesions using the characteristics of energy-based surgical instruments. We have found that TVRS is feasible in practice for patients with special clinical situations, and the recovery of pulmonary function and the incidence of complications were acceptable. Overall, our cohort was a series of patients with unusual clinical situations. In the current study, all patients were diagnosed with primary lung cancer by imaging examination, and the presence of pulmonary bullae was discovered at the same time. The main pathological characteristics of the recruited patients were ipsilateral primary lung cancer and bullae located in different lobes of the lung. In the case of radical resection of malignant lesions, the expansion of the lung resection range due to accompanied benign lesions may reduce the tolerance to surgery and affect postoperative lung function. Several studies (2426) also indicated that the postoperative pulmonary function of lung cancer patients decreased in a long-term follow-up period regardless of the surgical procedure. This may lead to a potential risk of postoperative adverse events caused by postoperative pulmonary dysfunction, especially in patients with preoperative chronic pulmonary disease. Therefore, we expected this novel procedure to preserve lung function as much as possible. Emphysema-affected lung tissue may constrict functional lung tissues and limit normal respiratory function. One of the principles of TVRS is that this procedure helps to relieve the compression of lung tissues by emphysema and restore normal lung function, and the postoperative outcome confirmed our prediction. The surgical treatment and prognosis of lung cancer were unaffected by the TVRS procedure, confirming the effectiveness and safety of TVRS. In addition, no special preparations were required for simultaneous surgery on the pulmonary bullae.

Based on these surgical experiences, we can summarize the potential advantages of TVRS for selected patients: (1) Double-lumen endotracheal tubes were used during anesthesia for TVRS, and normal ventilation of the healthy lung was ensured when air leakage occurred in the target lung. (2) Local thermal treatment exerted a bactericidal effect and reduced the risk of postoperative infection. (3) TVRS was able to preserve normal lung tissues to the maximum extent, since there was no need to dissect any lung tissue, and it was simultaneously able to preserve the integrity of lung tissue, especially in our patients who underwent essential lung dissection for lung cancer. (4) The automatic hemostasis procedure was more effective after local thermal treatment by electrocautery, and protein exudation from lung tissues increased following thermal treatment, which prevented alveolar surface rupture and air leakage. (5) Compared with the existing thermal ablation procedure, TVRS is characterized by a simple protocol, low cost and extensive range of applications.

The major limitations of our study were as follows: (1) The data of the current study were from a single-arm retrospective cohort, and no control group was included to compare the suitability of other surgical methods in this selected cohort. A previous study (8) indicated that thermal ablation with other instruments was no more beneficial than conventional therapy; therefore, it is necessary to perform a prospective, controlled trial to confirm the application range of TVRS. (2) No evidence was found to confirm whether the TVRS procedure can be expanded beyond the patients included in our study to a wider group of patients with severe emphysema, although, in light of its surgical principle, TVRS has some potential benefits.

Conclusion

In conclusion, we reported a new thermal-based surgical treatment successfully performed in a specific patient group diagnosed with primary lung cancer accompany with pulmonary bullae to reduce the enlargement lung tissue and the procedure did not interfere with the resection of malignant lung tumors. We suggest that thermal-based surgical treatment may be regarded as a potential choice for the treatment of pulmonary bullae in specific clinical situation.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by the Institutional Review Board of Jilin Cancer Hospital (No. 201412-028). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.

Author Contributions

TL completed the manuscript writing. WL completed the reviewing of manuscript and supplement of image and video. All authors completed study design, data collection, and analysis.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fsurg.2021.672688/full#supplementary-material

Supplementary Video 1. The burning procedure in TVRS, and the application of using gauze soaked in normal saline can be applied to cover the operating surface during the burning procedure.

References

1. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. (2004) 364:709–21. doi: 10.1016/S0140-6736(04)16900-6

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Kawamoto N, Okita R, Hayashi M, Furukawa M, Inokawa H, Okabe K. Rapid development and rupture of a pulmonary cyst in the early postoperative period after pulmonary resection: a case report. Thorac Cancer. (2020) 11:1712–15. doi: 10.1111/1759-7714.13421

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Cooper JD, Patterson GA. Lung volume reduction surgery for severe emphysema. Semin Thorac Cardiovasc Surg. (1996) 8:52–60.

PubMed Abstract | Google Scholar

4. van Agteren JE, Carson KV, Tiong LU, Smith BJ. Lung volume reduction surgery for diffuse emphysema. Cochrane Database Syst Rev. (2016) 10:CD001001. doi: 10.1002/14651858.CD001001.pub3

PubMed Abstract | CrossRef Full Text | Google Scholar

5. van Geffen WH, Slebos DJ, Herth FJ, Kemp SV, Weder W, Shah PL. Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis. Lancet Respir Med. (2019) 7:313–24. doi: 10.1016/S2213-2600(18)30431-4

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Hartman JE, Vanfleteren LEGW, van Rikxoort EM, Klooster K, Slebos DJ. Endobronchial valves for severe emphysema. Eur Respir Rev. (2019) 28:180121. doi: 10.1183/16000617.0121-2018

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Klooster K, ten Hacken NH, Hartman JE, Kerstjens HA, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. (2015) 373:2325–35. doi: 10.1056/NEJMoa1507807

PubMed Abstract | CrossRef Full Text | Google Scholar

8. McKenna RJ Jr, Brenner M, Gelb AF, Mullin M, Singh N, Peters H, et al. A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. J Thorac Cardiovasc Surg. (1996) 111:317–21. doi: 10.1016/S0022-5223(96)70440-3

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg. (2009) 88:1993–8. doi: 10.1016/j.athoracsur.2009.06.038

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis. (2012) 7:397–405. doi: 10.2147/COPD.S31082

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Gompelmann D, Eberhardt R, Schuhmann M, Valipour A, Shah PL, Herth FJ, et al. Lung volume reduction with vapor ablation in the presence of incomplete fissures: 12-month results from the STEP-UP randomized controlled study. Respiration. (2016) 92:397–403. doi: 10.1159/000452424

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Gompelmann D, Shah PL, Valipour A, Herth FJF. Bronchoscopic thermal vapor ablation: best practice recommendations from an expert panel on endoscopic lung volume reduction. Respiration. (2018) 95:392–400. doi: 10.1159/000489815

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Jones PW, Quirk FH, Baveystock CM. The St George's respiratory questionnaire. Respir Med. (1991) 85:25–31. doi: 10.1016/S0954-6111(06)80166-6

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Brantigan OC, Mueller E. Surgical treatment of pulmonary emphysema. Am Surg. (1957) 23:789–804.

PubMed Abstract | Google Scholar

15. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. (2003) 348:2059-73. doi: 10.1056/NEJMoa030287

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Ginsburg ME, Thomashow BM, Bulman WA, Jellen PA, Whippo BA, Chiuzan C, et al. The safety, efficacy, and durability of lung-volume reduction surgery: A 10-year experience. J Thorac Cardiovasc Surg. (2016) 151:717–24.e1. doi: 10.1016/j.jtcvs.2015.10.095

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Lim E, Sousa I, Shah PL, Diggle P, Goldstraw P. Lung volume reduction surgery: reinterpreted with longitudinal data analyses methodology. Ann Thorac Surg. (2020) 109:1496–501. doi: 10.1016/j.athoracsur.2019.11.018

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA. (2016) 315:2178–89. doi: 10.1001/jama.2016.6261

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Slebos DJ, Cicenia J, Sciurba FC, Criner GJ, Hartman JE, Garner J, et al. Predictors of response to endobronchial coil therapy in patients with advanced emphysema. Chest. (2019) 155:928–37. doi: 10.1016/j.chest.2019.02.012

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Dransfield MT, Garner JL, Bhatt SP, Slebos DJ, Klooster K, Sciurba FC, et al. Effect of zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year. Results from a randomized clinical trial. Ann Am Thorac Soc. (2020). 17:829–38. doi: 10.1513/AnnalsATS.201909-666OC

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Iftikhar IH, Schimmel M, Sardi A, Mehta I, Gonzalez E, Musani AI. Bronchoscopic lung volume reduction with valves and coils. A network meta-analysis. Ann Am Thorac Soc. (2020) 17:1468–75. doi: 10.1513/AnnalsATS.202002-151OC

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Li S, Wang G, Wang C, Gao X, Jin F, Yang H, et al. The REACH trial: a randomized controlled trial assessing the safety and effectiveness of the Spiration® valve system in the treatment of severe emphysema. Respiration. (2019) 97:416–27. doi: 10.1159/000494327

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS Randomized clinical trial. JAMA. (2016) 315:175–84. doi: 10.1001/jama.2015.17821

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Kim SJ, Ahn S, Lee YJ, Park JS, Cho YJ, Cho S, et al. Factors associated with preserved pulmonary function in non-small-cell lung cancer patients after video-assisted thoracic surgery. Eur J Cardiothorac Surg. (2016) 49:1084–90. doi: 10.1093/ejcts/ezv325

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Seok Y, Jheon S, Cho S. Serial changes in pulmonary function after video-assisted thoracic surgery lobectomy in lung cancer patients. Thorac Cardiovasc Surg. (2014) 62:133969. doi: 10.1055/s-0033-1343980

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Kobayashi N, Kobayashi K, Kikuchi S, Goto Y, Ichimura H, Endo K, et al. Long-term pulmonary function after surgery for lung cancer. Interact Cardiovasc Thorac Surg. (2017) 24:727–32. doi: 10.1093/icvts/ivw414

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: lung volume reduction surgery, thermal ablation, lung, pulmonary bullae, electrocautery

Citation: Lu T and Lu W (2021) Thermal Volume Reduction Surgery for Surgical Treatment of Pulmonary Bullae: A Single-Center Treatment Experience of 276 Cases Accompany With Primary Lung Cancer. Front. Surg. 8:672688. doi: 10.3389/fsurg.2021.672688

Received: 26 February 2021; Accepted: 12 April 2021;
Published: 04 May 2021.

Edited by:

Paola Ciriaco, San Raffaele Scientific Institute (IRCCS), Italy

Reviewed by:

Karin Klooster, University Medical Center Groningen, Netherlands
Stefano Viscardi, San Raffaele Hospital (IRCCS), Italy

Copyright © 2021 Lu and Lu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Weiping Lu, 840480338@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.